The incidence rate of hepatitis A is 3(-6)/1000 per month of stay in a developing country in unprotected travellers. Tramps and other persons feeding themselves under bad hygienic conditions have a rate of 20/1000. In many industrialized countries, persons below the age of 50 years have a seroprevalence rate of anti-HAV < 20%. Hepatitis A morbidity and mortality rates in travellers are far greater than those of any other vaccine-preventable infection in travellers, with the exception that hepatitis B shows a slightly greater mortality rate in expatriates. Future studies will determine the role of hepatitis C and E. Typhoid fever shows an incidence rate of 0.3/1000 in foreigners on the Indian subcontinent, and in many parts of North and West...
Background. Uncertainty exists about the current risk of hepatitis A virus infection in nonimmune tr...
Considering the geographical asymmetric distribution of viral hepatitis A, B and E, having a much hi...
To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all vis...
OBJECTIVE: To assess the risk of hepatitis A in international travelers and to recommend preventive ...
Each year ∼14 million Europeans travel to developing countries in Africa, Asia, and Latin American a...
Hepatitis A is the most common form of acute viral hepatitis in the world. Major geographical differ...
International audienceThe hepatitis A virus (HAV) is a leading cause of acute viral hepatitis worldw...
Hepatitis B is endemic in much of Asia, Africa, and parts of South America, regions that are increas...
Hepatitis A virus (HAV) is transmitted mostly through exposure to contaminated food or water, or thr...
Hepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic countries to...
Hepatitis B virus (HBV) infection is a serious global public health problem. The infection may be tr...
Background. Hepatitis A viral infection poses a substantial risk for travelers from low‐endemic coun...
BACKGROUND: Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-...
textabstractHepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic ...
summary. Travel to endemic areas is one of the most frequently reported risk factors for infection w...
Background. Uncertainty exists about the current risk of hepatitis A virus infection in nonimmune tr...
Considering the geographical asymmetric distribution of viral hepatitis A, B and E, having a much hi...
To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all vis...
OBJECTIVE: To assess the risk of hepatitis A in international travelers and to recommend preventive ...
Each year ∼14 million Europeans travel to developing countries in Africa, Asia, and Latin American a...
Hepatitis A is the most common form of acute viral hepatitis in the world. Major geographical differ...
International audienceThe hepatitis A virus (HAV) is a leading cause of acute viral hepatitis worldw...
Hepatitis B is endemic in much of Asia, Africa, and parts of South America, regions that are increas...
Hepatitis A virus (HAV) is transmitted mostly through exposure to contaminated food or water, or thr...
Hepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic countries to...
Hepatitis B virus (HBV) infection is a serious global public health problem. The infection may be tr...
Background. Hepatitis A viral infection poses a substantial risk for travelers from low‐endemic coun...
BACKGROUND: Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-...
textabstractHepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic ...
summary. Travel to endemic areas is one of the most frequently reported risk factors for infection w...
Background. Uncertainty exists about the current risk of hepatitis A virus infection in nonimmune tr...
Considering the geographical asymmetric distribution of viral hepatitis A, B and E, having a much hi...
To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all vis...